Search

Your search keyword '"Kubica, Jacek"' showing total 644 results

Search Constraints

Start Over You searched for: Author "Kubica, Jacek" Remove constraint Author: "Kubica, Jacek" Language english Remove constraint Language: english
644 results on '"Kubica, Jacek"'

Search Results

1. Efficacy and Safety of P2Y12 monotherapy vs standard DAPT in patients undergoing percutaneous coronary intervention: meta-analysis of randomized trials

6. Repetitive use of LEvosimendan in Ambulatory Heart Failure patients (LEIA-HF) - The rationale and study design

7. Lipoprotein (a) and the Occurrence of Lipid Disorders and Other Cardiovascular Risk Factors in Patients without Diagnosed Cardiovascular Disease.

8. A Systematic Review and Meta-Analysis of the Diagnostic Value of Galectin-3 in Acute Coronary Syndrome.

9. Drug-Eluting Balloons and Drug-Eluting Stents in Diabetic Patients Undergoing Percutaneous Coronary Intervention Due to Restenosis—DM-Dragon Registry.

10. Sex Differences in Fractional Flow Reserve Utilization.

12. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

13. Development and Validation of a Practical Model to Identify Patients at Risk of Bleeding After TAVR

15. Proposal and practicality of an alternative blue-light hazard risk assessment method for high-intensity white-light sources at workplaces.

17. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

19. Dual vs single antiplatelet therapy in patients with lower extremity peripheral artery disease – A meta-analysis

21. Gender-Related Effectiveness of Personalized Post-COVID-19 Rehabilitation.

23. First-year follow-up costs of myocardial infarction management in Poland from the payer's perspective.

25. Recommendations of the Experts of the Polish Cardiac Society (PCS) and the Polish Lipid Association (PoLA) on the diagnosis and management of elevated lipoprotein(a) levels.

26. Strategy of lipid-lowering treatment in patients with acute coronary syndrome. The ELECTRA-SIRIO 2 investigators' viewpoint.

27. A systematic review and meta-analysis of the impact of the pandemic on dispatcher-assisted cardiopulmonary resuscitation.

28. Impact of early levosimendan administration in patients with decompensated chronic heart failure on oxidative stress parameters -- the rationale and study design.

29. The use of andexanet alpha in the Polish setting: An interdisciplinary protocol Expert consensus statement of the Polish Cardiac Society.

31. Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapy

34. PLATELET-TO-LYMPHOCYTE RATIO AS A PROGNOSTIC BIOMARKER FOR COVID-19 SEVERITY: A SINGLE CENTER RETROSPECTIVE DATA ANALYSIS AND SYSTEMATIC REVIEW WITH META-ANALYSIS OF 187 STUDIES.

35. Management of myocardial infarction complicated by cardiogenic shock: Expert opinion of the Association of Intensive Cardiac Care and Association of Cardiovascular Interventions of the Polish Society of Cardiology.

41. COVID-19 occurrence and symptoms depending on vaccination status: a retrospective single-centre analysis of 27,209 patients.

44. Comprehensive Meta-Analysis of Safety and Efficacy of Bivalirudin Versus Heparin With or Without Routine Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndrome

47. Survival in nonagenarians with acute myocardial infarction in 2014-2020: A nationwide analysis.

50. Efficacy of double vs. standard empagliflozin dose for METabolic syndromE tReatment (DEMETER — SIRIO 11) study. Rationale and protocol of the study.

Catalog

Books, media, physical & digital resources